QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary 期刊论文 JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 卷号: 20 作者:  Chen, Kaiyan;  Zhang, Fanrong;  Yu, Xiaoqing;  Huang, Zhiyu;  Gong, Lei 收藏  |  浏览/下载：27/0  |  提交时间：2022/05/16 Cancer with unknown primary (CUP)  Multiple primary tumor  Comprehensive genomic profiling (CGP)  DNA methylation  Machine learning  Lung cancer   A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib 期刊论文 CLINICAL LUNG CANCER, 2021, 卷号: 22 作者:  Chen, Kaiyan;  Zhang, Fanrong;  Pan, Guoqiang;  Sheng, Jiamin;  Ye, Junyi 收藏  |  浏览/下载：27/0  |  提交时间：2021/03/15 Crizotinib  MET  Non-small-cell lung cancer  RET  Resistance   Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions 期刊论文 THORACIC CANCER, 2020 作者:  Chen, Kaiyan;  Pan, Guoqiang;  Cheng, Guoping;  Zhang, Fanrong;  Xu, Yanjun 收藏  |  浏览/下载：40/0  |  提交时间：2020/12/28 EGFR  HER2  immunotherapy  NSCLC  PD‐  L1   Development of a serum miRNA panel for detection of early stage non-small cell lung cancer 期刊论文 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 卷号: 117 作者:  Ying, Lisha;  Du, Lingbin;  Zou, Ruiyang;  Shi, Lei;  Zhang, Nan 收藏  |  浏览/下载：59/0  |  提交时间：2020/11/30 blood biomarker  microRNA  early detection   PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy 期刊论文 LUNG CANCER, 2020, 卷号: 142 作者:  Chen, Kaiyan;  Cheng, Guoping;  Zhang, Fanrong;  Zhu, Guanxia;  Xu, Yanjun 收藏  |  浏览/下载：24/0  |  提交时间：2020/11/26 Uncommon EGFR  Non-small cell lung cancer  PD-L1  T cell  Immunotherapy   Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2020, 卷号: 8 作者:  Huang, Minran;  Jin, Jiaoyue;  Zhang, Fanrong;  Wu, Yingxue;  Xu, Chenyang 收藏  |  浏览/下载：31/0  |  提交时间：2020/11/26 Esophageal squamous cell carcinoma (ESCC)  TP53 mutation  next-generation sequencing (NGS)  prognosis